How are Acne Vulgaris Patients Using Oral Isotretinoin Affected by COVID-19?
Introduction: It has been reported that the use of oral isotretinoin may have positive and negative effects on the course of COVID-19 and the risk of transmission. Objectives: The purpose of our study is to evaluate how our patients that took oral isotretinoin during the pandemic were affected by...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mattioli1885
2022-07-01
|
| Series: | Dermatology Practical & Conceptual |
| Subjects: | |
| Online Access: | http://dpcj.org/index.php/dpc/article/view/2111 |
| _version_ | 1818501459064389632 |
|---|---|
| author | Mine Müjde Kuş Perihan Öztürk Tutku Bulut Celal Kuş Mehmet Enes Güner Hülya Nazik Mehmet Kamil Mülayim |
| author_facet | Mine Müjde Kuş Perihan Öztürk Tutku Bulut Celal Kuş Mehmet Enes Güner Hülya Nazik Mehmet Kamil Mülayim |
| author_sort | Mine Müjde Kuş |
| collection | DOAJ |
| description |
Introduction: It has been reported that the use of oral isotretinoin may have positive and negative effects on the course of COVID-19 and the risk of transmission.
Objectives: The purpose of our study is to evaluate how our patients that took oral isotretinoin during the pandemic were affected by COVID-19.
Methods: The clinical processes of moderate-to-severe acne vulgaris patients between March 2020 and February 2021 were evaluated.
Results: Of 102 moderate-to-severe acne patients, 67 were using oral isotretinoin and 35 were using a topical treatment. Of 27 patients who tested positive for COVID-19, 16 (59.3%) were using oral isotretinoin and 11(40.7%) were using topical treatment, there was no statistical difference in the rates of COVID-19 positivity between the two groups (P = 0.412). The rates of positive tests for COVID-19 were similar between contacted patients of two groups (P = 0.391). Loss of smell/taste was lower in patients using oral isotretinoin compared to patients receiving topical treatment (46.7% and 72.7%, respectively.). Headache symptoms were less common in patients using oral isotretinoin (P = 0.047).
Conclusions: The use of oral isotretinoin did not cause an increase or decrease in the risk of COVID-19 transmission. The patients using oral isotretinoin had a lower incidence of taste/smell loss and headache.
|
| first_indexed | 2024-12-10T20:56:27Z |
| format | Article |
| id | doaj.art-05bbc6b0d6e34dedbd2b262ce5b0d881 |
| institution | Directory Open Access Journal |
| issn | 2160-9381 |
| language | English |
| last_indexed | 2024-12-10T20:56:27Z |
| publishDate | 2022-07-01 |
| publisher | Mattioli1885 |
| record_format | Article |
| series | Dermatology Practical & Conceptual |
| spelling | doaj.art-05bbc6b0d6e34dedbd2b262ce5b0d8812022-12-22T01:33:56ZengMattioli1885Dermatology Practical & Conceptual2160-93812022-07-0112310.5826/dpc.1203a146How are Acne Vulgaris Patients Using Oral Isotretinoin Affected by COVID-19?Mine Müjde Kuş0Perihan Öztürk1Tutku Bulut2Celal Kuş3Mehmet Enes Güner4Hülya Nazik5Mehmet Kamil Mülayim6Kahramanmaraş Sütçü İmam University Faculty of Medicine, Department of Dermatology ";}Kahramanmaraş Sütçü İmam University, Faculty of Medicine, Department of Dermatology, Kahramanmaraş, TurkeyKahramanmaraş Sütçü İmam University, Faculty of Medicine, Department of Dermatology, Kahramanmaraş, TurkeyKahramanmaraş Sütçü İmam University, Faculty of Medicine, Department of Family Medicine, Kahramanmaraş, TurkeyKahramanmaraş Sütçü İmam University, Faculty of Medicine, Department of Dermatology, Kahramanmaraş, TurkeyKahramanmaraş Sütçü İmam University, Faculty of Medicine, Department of Dermatology, Kahramanmaraş, TurkeyKahramanmaraş Sütçü İmam University, Faculty of Medicine, Department of Dermatology, Kahramanmaraş, Turkey Introduction: It has been reported that the use of oral isotretinoin may have positive and negative effects on the course of COVID-19 and the risk of transmission. Objectives: The purpose of our study is to evaluate how our patients that took oral isotretinoin during the pandemic were affected by COVID-19. Methods: The clinical processes of moderate-to-severe acne vulgaris patients between March 2020 and February 2021 were evaluated. Results: Of 102 moderate-to-severe acne patients, 67 were using oral isotretinoin and 35 were using a topical treatment. Of 27 patients who tested positive for COVID-19, 16 (59.3%) were using oral isotretinoin and 11(40.7%) were using topical treatment, there was no statistical difference in the rates of COVID-19 positivity between the two groups (P = 0.412). The rates of positive tests for COVID-19 were similar between contacted patients of two groups (P = 0.391). Loss of smell/taste was lower in patients using oral isotretinoin compared to patients receiving topical treatment (46.7% and 72.7%, respectively.). Headache symptoms were less common in patients using oral isotretinoin (P = 0.047). Conclusions: The use of oral isotretinoin did not cause an increase or decrease in the risk of COVID-19 transmission. The patients using oral isotretinoin had a lower incidence of taste/smell loss and headache. http://dpcj.org/index.php/dpc/article/view/2111COVID-19; isotretinoin; smell; taste, headache. |
| spellingShingle | Mine Müjde Kuş Perihan Öztürk Tutku Bulut Celal Kuş Mehmet Enes Güner Hülya Nazik Mehmet Kamil Mülayim How are Acne Vulgaris Patients Using Oral Isotretinoin Affected by COVID-19? Dermatology Practical & Conceptual COVID-19; isotretinoin; smell; taste, headache. |
| title | How are Acne Vulgaris Patients Using Oral Isotretinoin Affected by COVID-19? |
| title_full | How are Acne Vulgaris Patients Using Oral Isotretinoin Affected by COVID-19? |
| title_fullStr | How are Acne Vulgaris Patients Using Oral Isotretinoin Affected by COVID-19? |
| title_full_unstemmed | How are Acne Vulgaris Patients Using Oral Isotretinoin Affected by COVID-19? |
| title_short | How are Acne Vulgaris Patients Using Oral Isotretinoin Affected by COVID-19? |
| title_sort | how are acne vulgaris patients using oral isotretinoin affected by covid 19 |
| topic | COVID-19; isotretinoin; smell; taste, headache. |
| url | http://dpcj.org/index.php/dpc/article/view/2111 |
| work_keys_str_mv | AT minemujdekus howareacnevulgarispatientsusingoralisotretinoinaffectedbycovid19 AT perihanozturk howareacnevulgarispatientsusingoralisotretinoinaffectedbycovid19 AT tutkubulut howareacnevulgarispatientsusingoralisotretinoinaffectedbycovid19 AT celalkus howareacnevulgarispatientsusingoralisotretinoinaffectedbycovid19 AT mehmetenesguner howareacnevulgarispatientsusingoralisotretinoinaffectedbycovid19 AT hulyanazik howareacnevulgarispatientsusingoralisotretinoinaffectedbycovid19 AT mehmetkamilmulayim howareacnevulgarispatientsusingoralisotretinoinaffectedbycovid19 |